Since cancers stem cells (CSCs) were first identified in leukemia in 1994, they have been considered promising therapeutic focuses on for malignancy therapy
Since cancers stem cells (CSCs) were first identified in leukemia in 1994, they have been considered promising therapeutic focuses on for malignancy therapy. extracellular matrix, and exosomes, have been shown to be extremely important regulators of CSCs. Molecules, vaccines, antibodies, and CAR-T (chimeric antigen receptor T cell) cells have been developed to specifically target CSCs,…